This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Glaucoma  • Ocular/ Adnexal Tumors  • Articles for Residents  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Daniel M. Albert, MD, MS; Ronald E. Gangnon, PhD; Hans E. Grossniklaus, MD; W. Richard Green, MD; Soesiawati Darjatmoko, BS; Amol D. Kulkarni, MD

Arch Ophthalmol. 2008;126(5):626-631.

Objectives  To study the histopathological features of latanoprost-treated irides with or without darkening, compared with non–latanoprost-treated irides.

Methods  Iridectomy specimens and patient history forms were independently examined by 3 ophthalmic pathologists in a masked fashion. Specimens were evaluated for premalignant changes and for differences in level of pigmentation and degrees of cellularity, inflammation, and vascular abnormalities.

Results  The specimens consisted of 22 latanoprost-treated darkened irides, 35 latanoprost-treated irides without darkening, and 35 non–latanoprost-treated irides. There was a statistically significant decrease in the number of nuclear invaginations and prominent nucleoli in latanoprost-treated darkened irides compared with the other 2 groups (P = .004 and P = .005, respectively). The average thickness and pigmentation of the anterior border layer was greater in the latanoprost-treated darkened irides than in the other 2 groups (P = .03 and P = .02, respectively). The latanoprost-treated darkened irides had increased pigmentation of the stroma (P < .001), stromal fibroblasts (P < .001), melanocytes (P = .005), vascular endothelium (P = .02), and adventitia (P < .001) relative to the other 2 groups.

Conclusions  There is no histopathological evidence of premalignant changes in latanoprost-treated darkened irides. The latanoprost-induced iris color changes are due to a thickening of the anterior border layer and an increased amount of melanin in the anterior border layer and within the stromal melanocytes.

Author Affiliations: Departments of Ophthalmology and Visual Sciences (Drs Albert and Kulkarni and Mr Darjatmoko) and Biostatistics and Medical Informatics (Dr Gangnon), University of Wisconsin School of Medicine and Public Health, Madison; and Departments of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia (Dr Grossniklaus), and Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland (Dr Green).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?